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INTRODUCTION
Pseudomonas aeruginosa, a Gram-negative obligate aerobe, is an opportunistic pathogen and that often causes nosocomial infections (Sekiguchi et al. 2007) . Pseudomonas aeruginosa is a particular risk to burn patients (Church et al. 2006 ) and immunocompromised individuals, such as cystic fibrosis (Lau et al. 2005) , transplant (Johnson et al. 2009 ), cancer (Elting et al. 1997) and AIDS patients (Meynard et al. 1999) . Pseudomonas aeruginosa shows wide-scale multidrug resistance. Accurate identification of P. aeruginosa is critical to patient management.
It can take >2 days to identify P. aeruginosa from clinical samples using traditional culture-biochemical methods. Therefore, it is desirable to develop a fast, sensitive, and accurate assay to detect this pathogen. Antibody-based detection cannot be used because of a lack of high avidity antibodies, so nucleic acidbased assays are generally used for detection of P. aeruginosa. Many researchers have reported the use of PCR for P. aeruginosa detection (McIntosh et al. 1992; Khan and Cerniglia 1994; De Vos et al. 1997; da Silva Filho et al. 1999; Jaffe et al. 2001; Spilker et al. 2004; Xu et al. 2004; Lavenir et al. 2007; Anuj et al. 2009 ). L lipoprotein is a P. aeruginosa outer membrane protein that is involved in resistance of the bacterium to antimicrobials. This protein is found only in this organism, so the protein or its gene could be suitable target for rapid identification of P. aeruginosa by molecular methods (Douraghi et al. 2014; Jami Al-Ahmadi and Zahmatkesh Roodsari 2016) . However, such assays (e.g. PCR) often require equipment (Anuj et al. 2009; Douraghi et al. 2014 ; Jami Al-Ahmadi and Zahmatkesh Roodsari 2016) that is not available in many settings.
Multiple cross displacement amplification (MCDA), a nucleic acid amplification technique (Wang et al. 2015) , has been applied in the detection of bacteria including Vibrio parahaemolyticus, Shigella spp. and Listeria monocytogenes (Wang et al. 2016a (Wang et al. ,b, 2017 . MCDA assays are conducted isothermally (at 60-69
• C), so only require a simple heater. MCDA methods are easy, fast, specific, and very sensitive (requiring as few as three bacterial cells). Amplicon detection can be performed using gold nanoparticlebased lateral flow biosensors (LFB) (Wang et al. 2016a (Wang et al. ,b, 2017 , a simple and equipment-free method. Here, we aimed to establish a MCDA-LFB assay to detect P. aeruginosa via the oprL gene (a P. aeruginosa-specific gene that encodes L lipoprotein) in pure cultures, then to apply the assay to clinical sputum samples. We also compared the performance of this method to routine methods used in the clinical laboratory, with a view to the application of our method in clinical practice.
MATERIALS AND METHODS

Reagents
QIAamp DNA Mini Kits (Qiagen, Beijing, China) were used for DNA extraction from cultured pure bacterial strains. QIAamp DNA Microbiome Kits were used for DNA extraction from clinical sputum samples. Loopamp kits and Loopamp Fluorescent Detection Reagent were from Eiken Chemical (Beijing). Malachite Green (MG) was obtained from Bei Jing-Hai Tai Zheng Yuan Technology Co., Ltd. (Beijing). Biotinylated bovine serum albumin (biotin) and rabbit anti-fluorescein antibody (anti-FITC Ab) were obtained from Abcam Co., Ltd. (Shanghai, China). Streptavidinimmobilized 30-nm gold nanoparticles (SA-G) were from Resenbio Co., Ltd. (Xi'an, China). Other LFB detection materials including membrane backing materials, sample and conjugate pads, nitrocellulose membrane and absorbent pads were from JieYi Biotechnology Co., Ltd. (Shanghai).
Primers and gold nanoparticle-based dipstick biosensor preparation
The primers used in this study are listed in Table 1 . Gold nanoparticle-based dipstick biosensors were prepared as described (Wang et al. 2016b) . HPLC-purified primers were synthesized by TsingKe Biotech Co., Ltd. (Beijing). Assembled biosensors (4-mm wide) were stored at room temperature in a desiccant gel.
Bacteria
The bacteria used in this study are listed in Table 2 . All strains were identified by reference methods (culture and biochemical methods) in the Department of Clinical Laboratory, Peking University Shougang Hospital; they were maintained in pure culture, and stored in 15% (w/v) glycerol broth at −70 • C. Before use, strains were subcultured on nutrient agar plates at 37
Genomic DNA was extracted from all strains using a DNA Mini Kit and stored at −20 • C. Pseudomonas aeruginosa strain SGH-PA001 DNA was used for analysis of assay performance and sensitivity, and for determination of the optimal reaction temperature, while DNA from Klebsiella pneumoniae SGH-KP001 and Staphylococcus epidermidis SGH-SE001 strains were used as negative controls. For sensitivity analysis, DNA of P. aeruginosa SGH-PA001 was serially diluted as indicated.
MCDA assay
MCDA reactions (25 μl) were performed as described previously (Wang et al. 2015 (Wang et al. , 2016a with some modification. Briefly, the reaction mixture included: 12.5 μl 2 × reaction mix (Loopamp DNA Amplification Kit); 0.4 μM displacement primers (F1 and F2); 0.8 μM amplification primers C1 and C2; 1.2 μM amplification primers R1, R2, D1 and D2; 1.2 μM cross primer CP1; 2.4 μM cross primer CP2; 1.25 μl Bst DNA polymerase (10 U); and DNA template (1 μl). Negative control mixtures contained 10 ng To verify the primers, we designed for the P. aeruginosa-MCDA-LFB assay; the reactions were initially set at 62
• C for 40 min and then terminated the amplification by heating at 85
• C for 5 min. The optimal reaction temperature for P. aeruginosa-MCDA assay was then determined in reactions at fixed temperatures from 60 to 69
Amplicons were analyzed by four different methods: a colorimetric indicator (MG), 2% agarose gel electrophoresis, by using a turbidimeter (Loopamp Realtime Turbidimeter LA-320C) and by LFB detection. When using MG, the amplified products cause a change in the solution from colorless to sky blue (negative/blank controls remain colorless). In electrophoresis, reaction products were separated by applying 100 V across the gel for at least 30 min. DNA amplifications were visualized by exposing the gel to UV light, a specific ladder of bands is observed for positive amplifications, but not negative controls. On the LFB, two red lines (the test line and the control line) are observed for positive reactions, but the control line only is visualized for negative and blank control reactions.
Assessment of MCDA-LFB assay
Specificity of the MCDA-LFB assay for P. aeruginosa was analyzed using DNA from 40 bacterial strains (Table 2) including two other Pseudomonas species, and 28 non-Pseudomonas strains. The detection limit was defined in terms of the amount of the genomic DNA template. Assays were repeated at least twice. Detection of P. aeruginosa by MCDA-LFB was compared to that using the other three methods (see above) for three replicates of each template diluted to 10 ng/μl -10 fg/μl.
Application of P. aeruginosa-MCDA-LFB assay to human clinical sputum samples
To explore the application of the P. aeruginosa-MCDA-LFB assay to human clinical samples, 120 human sputum samples were collected from the Department of Clinical Laboratory, Peking University Shougang Hospital, which were previously identified by culture and biochemical methods (reference methods) and stored at −70
• C until use. By the reference method, 60 (50%) of the 120 samples were identified as P. aeruginosa positive, while the remainder were identified as containing other bacteria or negative. The consistency of results from P. aeruginosa-MCDA-LFB assays was compared with those from the reference method and also with the conventional PCR method. All patients who provided samples gave written informed consent. This study was approved by the Ethics Committee of Shougang Hospital, and conducted according to the regulations of the Ministry of Health, China.
RESULTS
Detection of P. aeruginosa-MCDA products
To confirm the effectiveness of the primers targeting the oprL gene of P. aeruginosa (Table 1) , MCDA assays were performed at 62
• C for 40 min using DNA from pure culture as the template. Amplification product was observed when the template was DNA from P. aeruginosa SGH-PA001, but not with DNA from K. pneumoniae SGH-KP001 or S. epidermidis SGH-SE001 (negative controls), or for the blank control (Fig. 1) . Therefore, the P. aeruginosa-MCDA primer set in current study was suitable for development of the MCDA-LFB assay.
Optimal assay temperature
Pseudomonas aeruginosa SGH-PA001 DNA was used (1 pg/reaction); reactions were monitored by real-time turbidity. The MCDA assay was conducted from 60 to 69
• C. The kinetic data in Fig. 2 show that 67
• C was the optimum reaction temperature.
Assay specificity and sensitivity
When DNA from 40 bacterial strains was tested by MCDA-LFB assay, only P. aeruginosa DNA produced positive results. Amplification products were not detected when the template was DNA from other Pseudomonas species or from non-Pseudomonas strains (Table 2) . Just 10 fg of P. aeruginosa template DNA gave amplicons that could be detected colorimetrically, by turbidity, by electrophoresis or by LFB (Fig. 3) . The results obtained using the LFB agreed completely with those by the other methods. Only 40 min was required to complete the reaction.
Detection of P. aeruginosa in clinical sputum samples by MCDA-LFB
A total of 120 clinical sputum samples were detected using P. aeruginosa-MCDA-LFB and conventional PCR (Table 3) . By the reference method, 60 of the 120 clinical samples were positive for P. aeruginosa. The MCDA-LFB assay results were in complete agreement. However, the PCR assay only identified 52 positive samples.
DISCUSSION
This study shows that multiple cross displacement amplification targeting the oprL gene with detection by a gold nanoparticle-based LFB can be used to detect P. aeruginosa with excellent specificity and sensitivity. oprL is a P. aeruginosaspecific gene encoding L lipoprotein; this gene/protein has been used previously in detection methods for P. aeruginosa (De Vos et al. 1997; Goto et al. 2010; Douraghi et al. 2014 ; Jami Al-Ahmadi and Zahmatkesh Roodsari 2016). The assay produced positive results for all P. aeruginosa strains tested, both from pure cultures and clinical samples, and negative results for all other species of bacteria and blank controls. Thus, the P. aeruginosa-MCDA-LFB method is highly selective for P. aeruginosa.
When the MCDA products were directly analyzed using the LFB (Wang et al. 2016a (Wang et al. ,b, 2017 , detection took <5 min, which is faster than gel electrophoresis (at least 30 min), less subjective and error-prone than colorimetric detection, and does not require instrumentation (as does the turbidity method). Thus, LFB detection is preferable and advantageous for determining the MCDA assay results.
The P. aeruginosa-MCDA-LFB assay required only simple incubation at 67
• C for 40 min. Easy-to-use, suitable equipment is available, such as battery-powered hot blocks that can hold 96 reaction tubes at a time. The MCDA amplification can be conducted using commercial isothermal amplification kits; the cost of each reaction is about $US3.5, and the LFB costs around $US 2 per test. The assay does not require highly trained personnel or a certified laboratory, and thus labor costs can be low. Overall, therefore, the assay is very cost effective. Importantly, we successfully applied the P. aeruginosa-MCDA-LFB assay to clinical sputum samples, and the sensitivity and specificity were the same as those of the reference method (Table 3 ). The whole P. aeruginosa-MCDA-LFB procedure except for sample processing could be completed within 45 min. Our study suggests that the P. aeruginosa-MCDA-LFB assay has the potential for fast detection of P. aeruginosa in clinical settings. Soon, we will focus on other clinical sample types, such as blood, urine and throat swabs, for clinical application of the P. aeruginosa-MCDA-LFB assay.
In conclusion, a reliable, fast, inexpensive, technically simple, sensitive and specific oprL-MCDA-LFB assay was successfully developed to detect P. aeruginosa, a common cause of nosocomial infections in burn patients and other immunocompromised individuals. The use of an LFB provided an objective and easily interpretable output. This newly developed method has the same sensitivity and specificity as the established reference method and could be applied in clinical settings.
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